Soluble receptor activator of nuclear factor-kB ligand : involvement and significance as therapeutics in the osteolysis associated with breast cancer growth in the bone microenvironment
Soluble receptor activator of nuclear factor-kB ligand : involvement and significance as therapeutics in the osteolysis associated with breast cancer growth in the bone microenvironment
批准号:
21590442
负责人:
FUTAKUCHI Mitsuru
金额:
$3.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
了解癌细胞是如何诱导骨转移的,对于确定控制骨转移的新疗法至关重要。利用模拟乳腺癌诱导的骨转移相关的溶骨性改变的小鼠模型,我们确定组织蛋白酶G是在肿瘤骨(TB)界面上调的蛋白。此外,我们还发现组织蛋白酶G能够脱核因子受体激活剂-KB配体(RANKL)的胞外区,产生能够诱导破骨细胞前体分化和激活的活性可溶性版本(SRANKL)。组织蛋白酶G的主要来源似乎是破骨细胞。此外,我们还表明,在体内抑制组织蛋白酶G可以减少乳腺肿瘤。接下来,我们观察了sRANKL竞争性抑制剂OCIF在植入乳腺肿瘤细胞诱导骨溶解前(Pre)、骨溶解诱导后(POST)或整个实验期间(整个实验期)对小鼠的预防作用。在OCIF治疗前、治疗后和整体治疗组中,TB界面的肿瘤生长明显受到抑制。治疗前、治疗后及整体治疗组骨破坏程度均明显减轻。此外,无论治疗周期如何,OCIF治疗组的破骨细胞均明显减少。因此,我们的数据表明,抑制TB界面的组织蛋白酶G活性可能是治疗的靶点,而由组织蛋白酶G产生的sRANKL是预防和治疗乳腺癌骨转移的潜在靶点。
英文摘要
Understanding how cancer cells induce bone metastases is essential for the identification of new therapies to control bone metastasis. Using a mouse model that mimics osteolytic changes associated with breast cancer-induced bone metastases, we identified cathepsin G to be proteases that are up-regulated at the tumor bone(TB)-interface. Moreover, we showed that cathepsin G is capable of shedding the extracellular domain of receptor activator of nuclear factor-KB ligand(RANKL), generating active soluble version(sRANKL) that is capable of inducing differentiation and activation of osteoclast precursors. The major source of cathepsin G seems to be osteoclasts. Furthermore, we showed that in vivo inhibition of cathepsin G reduces mammary tumor. induced osteolysis.Next we examined the preventive effects of a competitive inhibitor of sRANKL, osteoprotegrin fusion protein(OCIF) was administered to mice before osteolysis induction by implantation of mammary tumor cells(pre), after osteolysis induction(post) or during the entire experimental period(whole). Tumor growth at the TB-interface was significantly suppressed in the pre as well as the post and whole treatment groups of OCIF. The extent of bone destruction was significantly reduced in the pre, post and whole treatment groups. In addition, significantly fewer osteoclasts wereobserved in the OCIF treatment groups regardless of treatment period.Together, our data indicate that inhibition of cathepsin G activity at the TB interface could be therapeutic targets, and sRANKL which is generated by cathepsin G is a potentially target for prevention as well as treatment of breast cancer bone metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.biochi.2008.06.012
发表时间:
2009-01-01
期刊:
BIOCHIMIE
影响因子:
3.9
作者:
[Iigo, Masaaki, Alexander, David B., Tsuda, Hiroyuki]
通讯作者:
Tsuda, Hiroyuki
Lack of promoting effect of titanium dioxide particles on ultraviolet B-initiated skin carcinogenesis in rats
二氧化钛颗粒对紫外线 B 引发的大鼠皮肤癌形成缺乏促进作用
DOI:
--
发表时间:
2011
期刊:
Food and Chemical Toxicology
影响因子:
4.3
作者:
[J Xu, Y Sagawa, M Futakuchi, K Fukamachim, DB Alexander, F Furukawa, Y Ikarashi, T Uchino, T Nishimura, A Morita, M Suzui, H Tsuda]
通讯作者:
H Tsuda
Crosstalk between TGFbeta and AKT/PTEN signaling pathway in the bone microenvironment : mechanism for tumor cell proliferation in the bone metastasis of breast cancer
骨微环境中TGFbeta与AKT/PTEN信号通路的串扰:乳腺癌骨转移中肿瘤细胞增殖的机制
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Hiraoka N, et al., Mitsuru Futakuchi Katsumi Fukamachi Masumi Suzui]
通讯作者:
Mitsuru Futakuchi Katsumi Fukamachi Masumi Suzui
DOI:
10.1186/1471-2407-11-304
发表时间:
2011-07-20
期刊:
BMC cancer
影响因子:
3.8
作者:
[Sadanandam A, Futakuchi M, Lyssiotis CA, Gibb WJ, Singh RK]
通讯作者:
Singh RK
Crosstalk between TGFbeta and AKT/PTEN signaling pathway in the bone microenvironment ; mechanism for tumor cell proliferation in the bone metastasis of breast cancer
骨微环境中TGFbeta与AKT/PTEN信号通路的串扰;
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Futakuchi, M., Fukamachi, K., and Suzui, M]
通讯作者:
M
共 29 条
Mechanisms of induction of cancer stem cells in the bone microenvironment ; involvement of drug resistance for bone metastasis
-
批准号:15K06837
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2015
-
负责人:FUTAKUCHI Mitsuru
-
依托单位:
Analysis of microRNA regulating malignant potential of mammary tumor in the bone microenvironment.
-
批准号:24501319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:FUTAKUCHI Mitsuru
-
依托单位:
MMP13 promotes prostate tumor growth in the bone microenvironment by activating TGF-β
-
批准号:19590400
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:FUTAKUCHI Mitsuru
-
依托单位:
海外基金